Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:32 AM
Ignite Modification Date:
2025-12-26 @ 10:32 AM
NCT ID:
NCT02690428
Eligibility Criteria:
Inclusion Criteria:
* Are male or female \> 18 years of age
* Have histologically confirmed, locally uncontrolled, solid cancer, with or without metastases, that cannot be treated surgically due to unresectability or inoperability
* Have one or more tumours assessable by MRI/CT or ultrasound and situated in such a way that at least a part of the tumour can be treated with IMILT without damage to surrounding vital structures or the skin
* Are candidates for ablative intervention also outside this study
* Have given informed verbal and written consent to participation in the trial
* Have an ECOG performance status \< 2 (Karnofsky \> 60%)
* Have stable haematologic, renal and hepatic functions
Exclusion Criteria:
* Are HIV positive
* Have an active autoimmune disease
* Are on systemic corticosteroid medication (local treatment with aerosol's and ointment is allowed)
* Have known bleeding disorders or are treated with anticoagulant medication
* Are pregnant or nursing
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02690428
Study Brief:
Protocol Section:
NCT02690428